促炎细胞因子
免疫系统
背景(考古学)
癌症
细胞因子
癌症研究
细胞毒性T细胞
免疫学
机制(生物学)
免疫疗法
医学
癌症治疗
翻译(生物学)
生物
癌细胞
计算生物学
癌症治疗
毒性
临床试验
细胞毒性
小分子
生物信息学
癌症免疫疗法
肿瘤免疫学
调节器
作者
Olivier Fesneau,Thomas M Duhen
出处
期刊:BioEssays
[Wiley]
日期:2025-11-02
卷期号:48 (1): e70086-e70086
被引量:1
摘要
IL-12 is a proinflammatory cytokine secreted by antigen-presenting cells. It promotes the differentiation of cytotoxic T cells, which makes it a strong candidate to boost the antitumor immune response in cancer patients. While its first use in humans faced severe toxicity, more recent approaches have been taken to limit toxicity while retaining its biologic function. These strategies, summarized in this review, include systemic and local delivery of IL-12 and demonstrated promising results in murine tumor models. However, their translation in cancer patients was met with limited efficacy. Recent evidence indicates that exposure to IL-12 results in the expression of immunoregulatory molecules by T cells, suggesting the existence of a negative feedback loop that might impair the antitumor immune response. Therefore, a more thorough understanding of the biology of IL-12 in the context of cancer is crucial to advance the design of novel clinical trials. This approach can lead to improved therapy regimens and promising results in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI